Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.2/5
Medy Tox Inc

Medy Tox Inc (086900 KS)

56
Analysis
Health CareSouth Korea
Medy-Tox Inc. is a biopharmaceutical company. The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.
more
bearishHugel Inc
14 Aug 2021 21:44

The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?

The fight to acquire Hugel Inc (145020 KS) is now finally down to between the GS Group led consortium and the Goldman Sachs led consortium.

Logo
499 Views
Share
bullishSK Bioscience
25 Apr 2021 20:56

KOSPI200 Index Rebalance Preview: Review Period Almost Complete; Short Selling Commences in a Week

There could be up to 6 inclusions and 8 exclusions at the KOSPI200 index review in June. The inclusions could outperform the exclusions as short...

Logo
433 Views
Share
bearishLG Chem Ltd
14 Apr 2021 20:15

LGChem/SKI Deal - Another Korea Discount Worry? Follow the Female Lead

IP protection is a big worry for Korean firms - has the 2 precedent cases in Korea in 2021 lower the value of IP from the view of international...

Logo
358 Views
Share
bullishMedy Tox Inc
28 Jul 2020 00:11

Medytox Rights Offer: Terms & Situations

Medytox, which used to be one of the bluechip names on KOSDAQ, announces a ₩130bil rights offering.It offers a total of 0.97M shares, which...

Logo
561 Views
Share
bearishHugel Inc
29 Jun 2020 10:11

Hugel Placement: A 5.2% Block Deal Sale

After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...

Logo
414 Views
Share
x